Retrieve available abstracts of 89 articles: HTML format
Single Articles
July 2025
PANG X, He Q, Huang J, Tang K, et al Epidemiological Trends and CD4+T Cell Recovery in HIV-1 Patients With HCV/HBV
Co-Infection: A Retrospective Cohort Study in Southwest China (2003-2024).
J Med Virol. 2025;97:e70465. PubMedAbstract available
MADSEN KL, Tranberg M, Norgaard P, Medina C, et al Feasibility of First-Void Urinary and Vaginal Self-Sampling for High-Risk Human
Papillomavirus Testing Among Women Living With Human Immunodeficiency Virus in
Guinea-Bissau-A Multicenter Cross-Sectional Study.
J Med Virol. 2025;97:e70466. PubMedAbstract available
MARSHALL VA, Knights SM, Cornejo Castro EM, Labo N, et al Kaposi Sarcoma-Associated Herpesvirus Sequencing in People Living With HIV in the
Southern United States Reveals Subtype Diversity and Multiple Infections.
J Med Virol. 2025;97:e70467. PubMedAbstract available
June 2025
ZHAO X, Lu C, Wang Z, Qiao F, et al Development of a HiFi-LAMP Assay for Detection of Human Pegivirus Type 1 RNA.
J Med Virol. 2025;97:e70423. PubMedAbstract available
TIEOSAPJAROEN W, Tran A, Maisano M, Kim CM, et al Trend and Associated Factors for Late and Advanced HIV Diagnoses in 2011-2022 in
Melbourne, Australia.
J Med Virol. 2025;97:e70430. PubMedAbstract available
DE OLIVEIRA KG, Vasconcelos MPA, Ton JT, Uehara SNO, et al A Comprehensive Molecular and Serological Investigation of Hepatitis A Virus
Among Patients With Suspected Acute Hepatitis: A Brazilian Study.
J Med Virol. 2025;97:e70449. PubMedAbstract available
May 2025
YANG T, Lei H, Li J, Liang Y, et al A Visual Nomogram Survival Prediction Model in Acquired Immune Deficiency
Syndrome (AIDS)-Related Diffuse Large B-Cell Lymphoma.
J Med Virol. 2025;97:e70359. PubMedAbstract available
KILLER A, Gliga S, Jensen BO, Park P, et al Functional Cure of Hepatitis B and D Coinfection After ART Nonadherence in a
Person With HIV.
J Med Virol. 2025;97:e70375. PubMed
ALICE M, Fabienne T, Jean-Christophe P Genetic Evolution Between HIV-1 Groups M and O: HIV-1/MO Recombinant Forms.
J Med Virol. 2025;97:e70358. PubMedAbstract available
MARONEY KJ, Ye Y, Sudenga SL, Diffalha SA, et al Higher Expression of HPV16 Derived E7_LI Transcript Observed in Men With HIV and
Recurrent Anal Cancer.
J Med Virol. 2025;97:e70371. PubMedAbstract available
JARY A, van der Zee RP, Jongen V, Ter Braak TJ, et al Molecular Insights Into the Natural History of Anal HSIL.
J Med Virol. 2025;97:e70397. PubMedAbstract available
April 2025
TADESE BK, You X, Ndao T, Tota JE, et al The Burden of HPV Infections and HPV-Related Diseases Among People With HIV: A
Systematic Literature Review.
J Med Virol. 2025;97:e70274. PubMedAbstract available
BANGWEN E, Berens-Riha N, de Vrij N, Ceulemans A, et al No Distinct Cytokine, Chemokine, and Growth Factor Blood Profile Associated With
Monkeypox Virus Clade IIb Infected Patients.
J Med Virol. 2025;97:e70320. PubMedAbstract available
WEI Q, Chen L, Yin Y, Pai M, et al Analysis of Blood Microbiome From People Living With HIV and Donors by 16S rRNA
Metagenomic Sequencing.
J Med Virol. 2025;97:e70341. PubMedAbstract available
DEMIRDJIAN S, Naik V, Margot N, Falkard B, et al Phenotypic Characterization of Replication-Impaired Lenacapavir-Resistant HIV
Clinical Isolates.
J Med Virol. 2025;97:e70340. PubMedAbstract available
March 2025
JIANG Q, Zhou Z, Du X, Li Y, et al Novel Function of NUP153 in HNF4alpha Transcriptional Upregulation Contributes to
Promoting HBV Replication.
J Med Virol. 2025;97:e70256. PubMedAbstract available
JIN Q, Zhou M, Sun M, Ning B, et al Global Temporal Trends in Mother-to-Child Transmission Disease Incidence Among
Women of Child-Bearing Age: An Analysis of Global Burden of Disease Study 2021
Data.
J Med Virol. 2025;97:e70283. PubMedAbstract available
LIU S, Liu P, Lu Q, Shen Y, et al The Compensatory Effect of S375F on S371F Is Vital for Maintaining the
Infectivity of SARS-CoV-2 Omicron Variants.
J Med Virol. 2025;97:e70242. PubMedAbstract available
AMEGASHIE EA, Kwayisi-Darkwah CK, Adusei-Poku M, Sikeola RO, et al Lipid Peroxidation and Glutathione Levels Among People Living With HIV
Co-infected With Human Coronaviruses in Ghana.
J Med Virol. 2025;97:e70301. PubMedAbstract available
SEBASTIAO CS, Bathy J, Nhampossa T, Santos A, et al Susceptibility to Lenacapavir Among Newly Diagnosed HIV-Positive Patients
Followed Up in Mozambique That Presented With Primary Antiretroviral Resistance
to Other Classes.
J Med Virol. 2025;97:e70317. PubMedAbstract available
ZHANG X, Wu S, Lin Y, Zhang W, et al Development of an Assay Evaluating the Inducible HIV-1 Latent Reservoir Based on
Reverse Transcription Droplet Digital PCR for Unspliced/Intact Viral RNA.
J Med Virol. 2025;97:e70295. PubMedAbstract available
BETTUZZI T, Lebbe C, Grolleau C Modern Approach to Manage Patients With Kaposi Sarcoma.
J Med Virol. 2025;97:e70294. PubMedAbstract available
February 2025
LUZ E, Marques M, Arriaga MB, Campos LM, et al Risk Factors for Viral Coinfections in Blood Donors in Bahia, Brazil.
J Med Virol. 2025;97:e70186. PubMedAbstract available
SILVESTRE C, Tuaillon E, Duroyon MM, Abrantes M, et al NK Count and Natural Cytotoxicity in Immune Nonresponders Versus Responders
Living With HIV.
J Med Virol. 2025;97:e70170. PubMedAbstract available
SHARMA D, Rai M, Singh A, Gaur R, et al Fullerene (C(60) & C(70))-Meso-Tris-4-Carboxyphenyl Porphyrin Dyads Inhibit Entry
of Wild-Type and Drug-Resistant HIV-1 Clades B and C.
J Med Virol. 2025;97:e70181. PubMedAbstract available
TYRBERG T, Hagberg L, Nilsson S, Grahn A, et al Incidence and Risk Factors for Varicella-Zoster Virus-Associated Central Nervous
System Infections: A Nationwide Swedish Retrospective Case-Control Study.
J Med Virol. 2025;97:e70166. PubMedAbstract available
Correction to "Fullerene (C60 & C70)-Meso-Tris-4-Carboxyphenyl Porphyrin Dyads
Inhibit Entry of Wild-Type and Drug-Resistant HIV-1 Clades B and C".
J Med Virol. 2025;97:e70232. PubMed
LI K, Luo L, Ji Y, Zhang Q, et al Urgent Focus on the Surgical Risks of People Living With HIV: A Systematic Review
and Meta-Analysis.
J Med Virol. 2025;97:e70260. PubMedAbstract available
HOTA M, Wondeu ALD, Abakar MF, Dezoumbe K, et al Integrated Seroprevalence and Genome-Based Study of SARS-CoV-2 Viral Strains in
N'Djamena: Insights Into Chad's COVID-19 Epicenter.
J Med Virol. 2025;97:e70234. PubMedAbstract available
LU Z, Dong B, Yao P, Huang Y, et al Characteristics of Human Papillomavirus Prevalence and Infection Patterns Among
Women Aged 35-65 in Fujian Province, China: A Nine-Year Retrospective
Observational Study.
J Med Virol. 2025;97:e70238. PubMedAbstract available
January 2025
XIAO Q, He S, Wang C, Liu Y, et al Urgent Call for Attention to HIV-Associated Lymphoma: After AIDS 2024, the 25th
International AIDS Conference.
J Med Virol. 2025;97:e70159. PubMed
ZANET E, Taborelli M, Tirelli U, Diez-Martin J, et al Long-Term Clinical Outcomes After Autologous Hematopoietic Stem Cell
Transplantation in 49 Individuals Living With HIV (PLWH) and Affected by
High-Risk or Relapsed Lymphoma: A European Experience of Continued Relevance for
PLWH.
J Med Virol. 2025;97:e70165. PubMedAbstract available
December 2024
WANG J, Ni S, Chen Q, Wang C, et al Discovery of a Novel Public Antibody Lineage Correlated With Inactivated
SARS-CoV-2 Vaccine and the Resultant Neutralization Activity.
J Med Virol. 2024;96:e70073. PubMedAbstract available
STICH M, Magalhaes VG, Burger F, Garbade SF, et al Elevated Soluble ACE2 Activity in Children and Adults After SARS-CoV-2 Exposure
Irrespective of Laboratory-Confirmed Infection.
J Med Virol. 2024;96:e70098. PubMedAbstract available
SHABIL M, Khatib MN, Ballal S, Bansal P, et al Effectiveness of Tecovirimat in Mpox Cases: A Systematic Review of Current
Evidence.
J Med Virol. 2024;96:e70122. PubMedAbstract available
CHEN X, Chen R, Wen L, Qin T, et al Long Noncoding RNA LINC02453 Inhibits HIV-1 Replication by Binding With SEC13 to
Regulate the Viral Productive Cycle.
J Med Virol. 2024;96:e70116. PubMedAbstract available
ZHANG J, Shao S, Chen X, Wang S, et al Genome-Wide Association Study of Persistent Anal Human Papillomavirus Infection
Among HIV-Positive Males in Taizhou, China: A Cohort Study.
J Med Virol. 2024;96:e70126. PubMedAbstract available
LIN W, He Y, Gu F, Hu F, et al Hepatic Flare Following Effective Antiretroviral Therapy Is Associated With HBsAg
Seroclearance in HBV/HIV-1 Co-Infection.
J Med Virol. 2024;96:e70114. PubMedAbstract available
CHEN F, Li D, Tang H, Ge L, et al Estimates of HIV Incidence, Prevalence, and Mortality in China 2018.
J Med Virol. 2024;96:e70048. PubMedAbstract available
November 2024
GUIRAUD V, Naizet A, Khan H, Benhafoun G, et al Fourth-Generation HIV Rapid Tests: Enhanced Sensitivity and Reduced Diagnostic
Window for HIV-1 Primary Infection Screening.
J Med Virol. 2024;96:e70044. PubMedAbstract available
LI X, Shi H, Shi H, Xu Y, et al Transmission Network and Phylogenetic Analysis Highlight the Role of Suburban
Population in HIV-1 Transmission Among Older Adults in Nanjing, Jiangsu Province,
China.
J Med Virol. 2024;96:e70035. PubMedAbstract available
LIU B, Zhang Q Systemic Immune-Inflammation-Based Biomarker and Fragility Fractures in People
Living With HIV: A 10-Year Follow-Up Cohort Study in China.
J Med Virol. 2024;96:e70052. PubMedAbstract available
WANG N, Lin Q, Fan H, Wang Y, et al BIC/FTC/TAF Benefits People Living With HIV After Omicron Breakthrough Infection
in Shortening Duration of Symptoms, Enhancing Specific Immune Response and
Increasing Total CD4 Cells.
J Med Virol. 2024;96:e70036. PubMedAbstract available
ZHAO H, He Y, Ling X, Hou H, et al Profiles of Lymphocyte Subtypes in HIV-Infected People With Different Immunologic
Responses to Antiretroviral Therapy.
J Med Virol. 2024;96:e70081. PubMedAbstract available
October 2024
KUHN D, Heinen N, Sutter K, Herrmann ST, et al Divergent autoantibody and cytokine levels in COVID-19 sepsis patients influence
survival.
J Med Virol. 2024;96:e29935. PubMedAbstract available
LV S, Lan Y, He Y, Li Q, et al Pretreatment drug resistance among people living with HIV from 2018 to 2022 in
Guangzhou, China.
J Med Virol. 2024;96:e29937. PubMedAbstract available
CHAIX ML, Terracol L, Nere ML, Stefic K, et al Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in
French primary HIV-1 infected patients in 2020-2023.
J Med Virol. 2024;96:e29948. PubMedAbstract available
ALIDJINOU EK Comments on "High efficacy of bictegravir/emtricitabine/tenofovir alafenamide
(B/F/TAF) in Black adults in the United States, including those with pre-existing
HIV resistance and suboptimal adherence".
J Med Virol. 2024;96:e29950. PubMed
ANDREATTA K, D'Antoni ML, Chang S, Parvangada A, et al High efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in
Black adults in the United States, including those with pre-existing HIV
resistance and suboptimal adherence.
J Med Virol. 2024;96:e29899. PubMedAbstract available
VELLAS C, Doudou A, Mohamed S, Raymond S, et al Comparison of short-read and long-read next-generation sequencing technologies
for determining HIV-1 drug resistance.
J Med Virol. 2024;96:e29951. PubMedAbstract available
September 2024
LO VT, Lim HA, Jang SS, Kim MC, et al N121T and N121S substitutions on the SARS-CoV-2 spike protein impact on serum
neutralization.
J Med Virol. 2024;96:e29871. PubMedAbstract available
GAY L, Desquiret-Dumas V, Nagot N, Rapenne C, et al Long-term persistence of mitochondrial dysfunctions after viral infections and
antiviral therapies: A review of mechanisms involved.
J Med Virol. 2024;96:e29886. PubMedAbstract available
PAN D, Mohamed B, Gupta A, Arshad Z, et al Clinical and molecular epidemiology of enterovirus infections in cerebrospinal
fluid samples, 2019-2023.
J Med Virol. 2024;96:e29924. PubMedAbstract available
August 2024
LI J, Lv J, Yu F, Zhang Y, et al Temporal changes in plasma metabolic signatures to predict immune response of
antiretroviral therapy among people living with HIV.
J Med Virol. 2024;96:e29798. PubMedAbstract available
MONTI B, Soria A, Saladini F, Lapadula G, et al Regaining virological suppression in a woman living with a six-class resistant
HIV by combining injectable antiretroviral drugs guided by genotypic and
phenotypic tests.
J Med Virol. 2024;96:e29832. PubMed
GUPTA A, Righi E, Konnova A, Sciammarella C, et al Interleukin-2-mediated CD4 T-cell activation correlates highly with effective
serological and T-cell responses to SARS-CoV-2 vaccination in people living with
HIV.
J Med Virol. 2024;96:e29820. PubMedAbstract available
SUTERIO DG, Hunter JR, Tenore SB, Pimentel SR, et al People living with HIV co-infected with the Kaposi Sarcoma-associated Herpes
Virus have a distinct HIV Tat profile and higher rates of antiretroviral
virologic failure, more evident among those with Kaposi's sarcoma.
J Med Virol. 2024;96:e29840. PubMedAbstract available
HEHE Z, Minna Z, Qin F, Tielin N, et al Application of molecular epidemiology in revealing HIV-1 transmission network and
recombination patterns in Tianjin, China.
J Med Virol. 2024;96:e29824. PubMedAbstract available
WANG Z, Wang W, Gao Z, Gao H, et al Structure-based design, synthesis, and biological characterization of
indolylarylsulfone derivatives as novel human immunodeficiency virus type 1
inhibitors with potent antiviral activities and favorable drug-like profiles.
J Med Virol. 2024;96:e29830. PubMedAbstract available
PIETROLUONGO E, Luciano A, Peddio A, Buonaiuto R, et al Exploring the interplay between Kaposi's sarcoma and SARS-CoV-2 infection: A case
series and systematic review.
J Med Virol. 2024;96:e29849. PubMedAbstract available
RIZZO A, Moschese D, Salari F, Giacomelli A, et al Anal HPV prevalence in individuals with and without other concomitant sexually
transmitted infections.
J Med Virol. 2024;96:e29852. PubMedAbstract available
PASSERINI S, Fracella M, Benvenuto D, Bugani G, et al High rates of anal Merkel Cell Polyomavirus and HPV co-infection among people
living with HIV.
J Med Virol. 2024;96:e29883. PubMedAbstract available
FOURY A, Saunier A, Taverniers A, Pinet N, et al The relevance of ultradeep sequencing for low HIV-1 viral loads and proviruses in
the clinical setting.
J Med Virol. 2024;96:e29870. PubMedAbstract available
July 2024
MCCLURE CP, Kean K, Reid K, Mayne R, et al Reconstruction of the historic time course of blood-borne virus contamination of
clotting factor concentrates, 1974-1992.
J Med Virol. 2024;96:e29774. PubMedAbstract available
LIANG Z, Lin C, Huo D, Yang Y, et al First detection of multiple cases related to CV-A16 strain of B1c clade in
Beijing in 2022.
J Med Virol. 2024;96:e29796. PubMedAbstract available
FANG T, Liu L, Mao S, Jiang Z, et al Association between virus infection and periodontitis: Evidence from the National
Health and Nutrition Examination Survey 2009-2014.
J Med Virol. 2024;96:e29784. PubMedAbstract available
ZHANG Y, Geng M, Xing Y, Ren X, et al Improvement and exacerbation of multiple disparities in sexually transmitted
infections among children and adolescents aged 6-22 years: An analysis of
national surveillance data from 2013 to 2021.
J Med Virol. 2024;96:e29808. PubMedAbstract available
MATSCHKE J, Hartmann K, Pfefferle S, Wang Y, et al Inefficient tissue immune response against MPXV in an immunocompromised mpox
patient.
J Med Virol. 2024;96:e29811. PubMedAbstract available
YAN H, Wu H, Li S, Wang J, et al The origin and spread of HIV-1 CRF59_01B epidemic in China: A molecular network
and phylogeographic analysis.
J Med Virol. 2024;96:e29799. PubMedAbstract available
June 2024
LI J, Xie DD, Cui HL, Yue C, et al Trends in the burden and determinants of HIV in the Asia-Pacific region
(1990-2019): An age-period-cohort analysis of the 2019 Global Burden of Disease
Study.
J Med Virol. 2024;96:e29724. PubMedAbstract available
CHEN R, Fu Y, Li D, Wang S, et al Proteomic analysis of plasma in healthy adults receiving recombinant vaccinia
virus provides novel insights into HIV-1 neutralizing antibodies.
J Med Virol. 2024;96:e29749. PubMedAbstract available
MOOKO T, Bisiwe FB, Chikobvu P, Morobadi MD, et al The prevalence of HIV resistance mutations and their influence on the shedding of
HIV-1 into peritoneal dialysis effluent.
J Med Virol. 2024;96:e29734. PubMedAbstract available
GU F, Zeng K, Lan X, He Y, et al Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV
functional cure in HIV/HBV-co-infected patients with HBsAg loss.
J Med Virol. 2024;96:e29762. PubMedAbstract available
May 2024
LIRA GS, Ota VA, Melo MQS, Castineiras ACP, et al Mpox outbreak in Rio de Janeiro, Brazil: A translational approach.
J Med Virol. 2024;96:e29621. PubMedAbstract available
RALLON N, Jimenez-Carretero D, Restrepo C, Ligos JM, et al A specific natural killer cells phenotypic signature associated to long term
elite control of HIV infection.
J Med Virol. 2024;96:e29646. PubMedAbstract available
MATUSALI G, Mazzotta V, Meschi S, Colavita F, et al JN.1 neutralizing antibody titers after XBB.1.5 monovalent vaccine boost in
healthcare workers and people with HIV.
J Med Virol. 2024;96:e29631. PubMed
RZYMSKI P, Zarebska-Michaluk D, Parczewski M, Genowska A, et al The burden of infectious diseases throughout and after the COVID-19 pandemic
(2020-2023) and Russo-Ukrainian war migration.
J Med Virol. 2024;96:e29651. PubMedAbstract available
HWANG JH, Hwang JH Is a 2-week regimen of tecovirimat sufficient for the treatment of Mpox
(monkeypox) in advanced HIV patients with a low CD4 cell count?
J Med Virol. 2024;96:e29617. PubMed
April 2024
KIM M, Kim E Effective vaccination strategies for human papillomavirus (HPV) infection and
cervical cancer based on the mathematical model with a stochastic process.
J Med Virol. 2024;96:e29558. PubMedAbstract available
JIANG X, Gao Z, Sharma PP, Kumar S, et al Discovery of low-molecular-weight phenylalanine derivatives as novel HIV capsid
modulators with improved antiretroviral activity and metabolic stability.
J Med Virol. 2024;96:e29594. PubMedAbstract available
MATUSALI G, Vergori A, Cimini E, Mariotti D, et al Poor durability of the neutralizing response against XBB sublineages after a
bivalent mRNA COVID-19 booster dose in persons with HIV.
J Med Virol. 2024;96:e29598. PubMedAbstract available
LI Y, Zhang X, Huang Y, Gao L, et al The prevalence of Human Immunodeficiency Virus infection among voluntary blood
donors in mainland China: A systematic review and meta-analysis.
J Med Virol. 2024;96:e29599. PubMedAbstract available
March 2024
XIAO J, Luo Y, Li Y, Yao X, et al The characteristics of BCR-CDR3 repertoire in COVID-19 patients and SARS-CoV-2
vaccinated volunteers.
J Med Virol. 2024;96:e29488. PubMedAbstract available
XIE M, Wang Z, Zhao F, Li Y, et al Structure-based design of diarylpyrimidines and triarylpyrimidines as potent
HIV-1 NNRTIs with improved metabolic stability and drug resistance profiles.
J Med Virol. 2024;96:e29502. PubMedAbstract available
CORMA-GOMEZ A, Cabello A, Orviz E, Morante-Ruiz M, et al Long or complicated mpox in patients with uncontrolled HIV infection.
J Med Virol. 2024;96:e29511. PubMedAbstract available
WANG Z Novel diarylpyrimidine subtypes as HIV-1 nonnucleoside reverse transcriptase
inhibitors with improved resistance profile.
J Med Virol. 2024;96:e29553. PubMed
TRUNFIO M, Tang B, Okwuegbuna O, Iudicello JE, et al Longitudinal analysis of CSF HIV RNA in untreated people with HIV: Identification
of CSF controllers.
J Med Virol. 2024;96:e29550. PubMedAbstract available
FARAONE JN, Wang X, Qu P, Zheng YM, et al Neutralizing antibody response to SARS-CoV-2 bivalent mRNA vaccine in
SIV-infected rhesus macaques: Enhanced immunity to XBB subvariants by two-dose
vaccination.
J Med Virol. 2024;96:e29520. PubMedAbstract available
KASSAM P, El-Zein M, Laurie C, Tota JE, et al Use of a carrageenan-based gel had no impact on anal HPVs 16 and 18 viral loads
in gay, bisexual, and other men who have sex with men.
J Med Virol. 2024;96:e29562. PubMedAbstract available